(Q77501492)
Statements
Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors (English)
Centers for Disease Control and Prevention (CDC)
1 reference